GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (STU:7JN) » Definitions » Gross-Profit-to-Asset %

Poolbeg Pharma (STU:7JN) Gross-Profit-to-Asset % : 0.00% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Poolbeg Pharma Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Poolbeg Pharma's annualized Gross Profit for the quarter that ended in Jun. 2024 was €0.00 Mil. Poolbeg Pharma's average Total Assets over the quarter that ended in Jun. 2024 was €16.64 Mil. Therefore, Poolbeg Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 0.00%.

Poolbeg Pharma Gross-Profit-to-Asset % Historical Data

The historical data trend for Poolbeg Pharma's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Gross-Profit-to-Asset % Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
- - -

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross-Profit-to-Asset % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Poolbeg Pharma's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Poolbeg Pharma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poolbeg Pharma's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poolbeg Pharma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Poolbeg Pharma's Gross-Profit-to-Asset % falls into.


;
;

Poolbeg Pharma Gross-Profit-to-Asset % Calculation

Poolbeg Pharma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0/( (22.179+17.908)/ 2 )
=0/20.0435
=0.00 %

Poolbeg Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=0/( (17.908+15.377)/ 2 )
=0/16.6425
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Poolbeg Pharma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Poolbeg Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (STU:7JN) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
LSE:AREC LSE:OPTI AQSE:PBX LSE:IMM LSE:IXI LSE:OBD LSE:SAR LSE:HEMO LSE:FAB AQSE:INC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
POLB:UK 7JN:Germany
Address
42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX
Website
https://www.poolbegpharma.com
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.

Poolbeg Pharma Headlines

No Headlines